Gland Pharma informs about monitoring agency report

22 Jan 2022 Evaluate

Pursuant to Regulation 41(4) of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and Regulation 32(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gland Pharma has informed that it enclosed Monitoring Agency Report dated January 21, 2022 in respect of utilization of proceeds of IPO for the quarter ended December 31, 2021 issued by Axis Bank, Monitoring Agency.

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1681.95 -39.70 (-2.31%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×